David Rosmarin, MD

Novel TYK2-Inhibitor for the Treatment of Plaque Psoriasis

03/29/2019

BMS-986165 is one such novel oral agent that inhibits tyrosine kinase 2 and is a promising future therapeutic agent for patients with plaque psoriasis.

BMS-986165 is one such novel...

03/29/2019

The Dermatologist

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

David Rosmarin, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products